Document is current
Any future updates will be listed below
-
Authors
Correia, Cristina
Maurer, Matthew J. https://orcid.org/0000-0002-1867-0526
McDonough, Samantha J.
Schneider, Paula A.
Ross, Paige E. https://orcid.org/0000-0002-4157-3951
Novak, Anne J. https://orcid.org/0000-0002-7904-1651
Feldman, Andrew L. https://orcid.org/0000-0001-5009-4808
Cerhan, James R. https://orcid.org/0000-0002-7482-178X
Slager, Susan L. https://orcid.org/0000-0002-5173-4712
Witzig, Thomas E. https://orcid.org/0000-0002-4215-6500
Eckloff, Bruce W.
Li, Hu https://orcid.org/0000-0001-5957-5472
Nowakowski, Grzegorz S. https://orcid.org/0000-0002-6955-9393
Kaufmann, Scott H. https://orcid.org/0000-0002-4900-7145
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA166742, P50 CA097274, P50 CA097274, P50 CA097274, U01 CA195568, P50 CA097274)
Mayo Clinic Center for Individualized Medicine
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 23 November 2022
Revised: 21 April 2023
Accepted: 27 April 2023
First Online: 17 May 2023
Competing interests
: A.L.F. has received research funding from Seattle Genetics, is an inventor of technology for which Mayo Clinic holds unlicensed patents, and is an inventor of intellectual property licensed to Zeno Pharmaceuticals. J.R.C. has received research funding from Genentech. The remaining authors declare no competing interests.
